期刊文献+

急性白血病相关融合基因MLL-EEN研究进展 被引量:1

Review on acute leukemia fusion gene MLL-EEN
下载PDF
导出
摘要 对白血病中大量重现的细胞遗传学异常分子水平研究揭示,遗传学异常在白血病发生中起重要作用。11q23易位是白血病中常见的细胞遗传学异常,含11q23基因重排的急性髓性白血病(acute myeloid leukemia,AML)预后不良。混合系白血病基因(mixed linage leu-kemia gene,MLL)基因定位于11q23,是果蝇三胸基因的人类同系物。目前与MLL发生融合的伙伴基因已超过40个,分布于约60个位点。EEN最初发现于1例t(11;19)(q23;p13)易位的AML患者,是在19p13位点发现的第3个MLL伙伴基因。MLL外显子6的N末端连接到EEN的16个氨基酸后的C末端,形成的融合蛋白包括MLL的AT钩和甲基转移酶同源区,以及EEN的α螺旋区和SH3结构域。MLL-EEN在白血病中的分子机制可能通过磷酸肌醇途径、调控HOX基因、抑制EBP相关的Ras活动、与其他基因的交互作用以及联合致病机制而起作用。目前对MLL-EEN的研究正逐渐深入,有效治疗白血病依赖于对白血病相关基因异常机制全面深入地研究。 Molecular study of many recurring cytogenetic abnormalities has revealed genes that may be involved in leukemogenesis. 11q23 translocation is one of the frequently reported abnormalities. Prognosis of AML with 11q23 rearrangements is poor. The human homologue of the Drosophila trithorax gene, MLL is located on chromosome 11q23, which is involved in translocations with over 40 different chromosome partners, and MLL is translocated to approximately 60 differ ent chromosomal loci. First identified from an AML patient with t(11 ;19)(q23;p13) translocations, EEN is the third gene characterized on chromosome 19p13 that fuses to MLL in hu- man leukemia. As exon 6 of MLL is fused to EEN at amino acid 16, the fusion product contains the AT hooks and methyltransferase homology regions of MLL, joined to the α-helical region and SH3 domain of EEN. The leukemogenesis mechanisms of MLL-EEN may be related to phosphoinositol pathway, HOX gene regulation, EBP related Ras activities suppression, interactions with other fusion partners or a synergic pathogenic mechanism. The effectiveness of treatment to this malicious disease depends on what depth we understand the nature of these mutations.
出处 《中华肿瘤防治杂志》 CAS 2007年第23期1834-1837,共4页 Chinese Journal of Cancer Prevention and Treatment
关键词 白血病/遗传学 基因 MLL 基因 EEN 基因融合 染色体 易位 遗传 综述文献 leukemia/genetics gene, MLL gene, EEN gene fusion chromosomes translocation, genetic review literature
  • 相关文献

参考文献4

二级参考文献53

  • 1Teller J K, Russo C, DeBusk L M, et al. Presence of soluble amyloid beta-peptide precedes amyloid plaque formation in Down's syndrome. Nat Med,1996,2(1):93-95.
  • 2Meng JY, Kataoka H, ltoh H, et al. Amyloid beta protein precursor is involved in the growth of human colon carcinoma cell in vitro and in vivo. J Cancer,2001,92(1):31-39.
  • 3Hansel DE, Rahman A, Wehner S, et al. Increased Expression and Processing of the Alzheimer Amyloid Precursor Protein in Pancreatic Cancer May Influence Cellular Proliferation. Cancer Res,2003,63(ll):7032-7037.
  • 4Baldus CD, Liyanarachchi S, Mrozek K,et al. Acute myeloid leukemia with complex karyotypes and abnormal chromosome 21: Amplification discloses overexpression of APP, ETS2, and ERG genes. PNAS, 2004, 101(11):3915-3920.
  • 5Pineault N, Abramovich C, Humphries RK. Transplantable cell lines generated with NUP98-Hox fusion genes undergo leukemic progression by Meisl independent of its binding to DNA.Leukemia, 2005,19 (4): 636-643.
  • 6Lahortiga I, Belloni E, Vazquez I, et al. NUP98 is fused to HOXA9 in a variant complex t(7;11;13;17) in a patient with AML-M2. Cancer Genet Cytogenet, 2005,157(2):151-156.
  • 7Kozu T, Fukuyama T, Yamami T, et al. MYND-Iess splice variants of AML1-MTG8 (RUNX1-CBFA2T1) are expressed in leukemia with t (8; 21). Genes Chromosomes Cancer, 2005, 43(1):45-53.
  • 8McKenzie SB. Advances in understanding the biology and genetics of acute myelocytic leukemia. Clin Lab Sci,2005,18(1 ):28-37.
  • 9Cheryl L, Willman MD. Biologic and genetic risk assessment of AML in the genomic era. American Society of Hematology Education Program Book, 2002: 90-97.
  • 10Sato H, Preisler H, Day R, et al. MDR1 transcript levels as an indication of resistant disease in acute myelogenous leukaemia. Br J Haematol, 1990, 75(3):340-345.

共引文献15

同被引文献8

  • 1Abutalib S A, Welzler M, Stock W. Looking toward the future novel strategies based on molecular pathogenesis of acute lyre phoblastic leukemia[J]. Hematol Oncol Clin North Am, 2009 23(5) :1099-1119.
  • 2Gokbuget N, Hoelzer D. Treatment of adult acute lymphobIastic leukemia[J]. Semin Hematol, 2009,46(1):64-75.
  • 3Marcueci G, Maharry K, Whitman S P, et al. High expression levels of the ETS-related gene, ERG, predict adverse outcome and improve molecular risk-based classification of cytogenetically normal acute myeloid leukaemia: a Cancer and leukaemia Group B Study[J]. J Clin Oncol, 2007, 25: 3337-8343.
  • 4Metzeler K H, Dufour A, Benthaus T, et al. ERG expression is an independent prognostic factor and allows refined risk stratification in cytogenetically normal acute myeloid leukemia: a comprehensive analysis of ERG, MN1, and BAALC transcript levels using oligonucleotide microarrays[J]. J Clin Oncol, 2009, 27(30): 5031- 5038.
  • 5Saechi N, Cheng S V, Tanzi R E, et al. The ETS genes on chromosome 21 are distal to the breakpoint of the acute myelogenous leukemia translocation (8;21)[J]. Genomics, 1988,3(2): 110 -116.
  • 6Marcucci G, Baldus C D, Ruppert A S, et al. Overexpression of the ETS related gene, ERG, predicts a worse outcome in acute myeloid leukemia with normal karyotype: a Cancer and Leukemia Group Bstudy[J]. J ClinOncol, 2005,23(36):9234 -9242.
  • 7Santamaria C M, Chillon M C, Garcia-Sanz R, et al. Molecular stratification model for prognosis in cytogenetieally normal acute myeloid leukemia[J]. Blood, 2009,114(1) :148- 152.
  • 8张丽君,王艳萍,卢香兰,何娟,李艳,翟明.急性淋巴细胞白血病AML1基因重排与MLL基因丢失同时出现临床意义的探讨[J].中华肿瘤防治杂志,2007,14(23):1801-1804. 被引量:2

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部